Regenesis
Cartilage Regeneration through Electrical Stimulations
Startup Pre-Funding Health Tech & Life Sciences Est. 2023
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
1
1-10 employees
Confidence
79/100
Patents
1
About
Regenesis is a biomedical startup aims to revolutionize treatment of cartilage lesions by in situ enhancement of cartilage regeneration. Our innovative solution enables full restoration of the cartilage through a minimally invasive procedure. Regenesis platform is based on a unique biocompatible structure designed to be applied directly or indirectly to the damaged area. The platform can be adopted for tissue regeneration of various medical conditions associated with cartilage damage. The platform can be adopted for tissue regeneration of various medical conditions. The company's portfolio includes include the treatment of hip and ankle lesions and treatment of Osteoarthritis (OA)
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Core Technology
Biologicals
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
regenerative-medicinemedical-devicesbioconvergenceminimally-invasivetissue-regenerationosteoarthritis
Details
Product Stage
R&D
Employees
1-10
Exact Count
1
District
North District
Founded
2023
Registrar
516774650
Locations
Industrial Area, Qatsrin
Links
Website
LinkedIn
Admin
Last Update
Jul 30, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
sector, video or image, funding rounds, news, markets, not claimed
Team (1)
Gadi Sarfati
CEO
Internal
Created by
Gadi Sarfati (gadi@regenesis.co.il)
Created
2024-04-09T00:00:00.000Z